CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
1.25 mg enalaprilat IV +1 moredrug
Likely dose
1.25 mg enalaprilat IVfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00248807
NCT00248807N/ACompleted

Systemic Hemodynamics and Cerebral Blood Flow in Persons With Tetraplegia

VA Office of Research and Development·interventional·Posted Nov 4, 2005·Updated Feb 25, 2025

In Brief

A clinical study evaluating 1.25 mg enalaprilat IV and Head up tilt (HUT) for Orthostatic Hypotension and Spinal Cord Injuries. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to determine how blood pressure and blood flow are controlled during head-up tilt in a semi-upright position. In this investigation we are studying blood pressure and blood flow to the brain, with and without a medication which lowers blood pressure (Vasotec). We will determine how persons with a spinal cord injury are able to maintain blood flow to the brain (not get dizzy) as they assume a more upright position and their blood pressure decreases.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 2005
Enrollment StartOct 1, 2005
Primary CompletionMay 1, 2009
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 20.7 years ago

Interventions

1.25 mg enalaprilat IVdrug

an angiotensin converting enzyme (ACE) inhibitor given to lower blood pressure (BP) and measure cerebral blood flow (CBF)

Head up tilt (HUT)other

45 degree head-up tilt to lower blood pressure and measure cerebral blood flow.